Browse diseases

…2Fasano S, Milone A, Nicoletti GF, et al. Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol. 2023;19(6):331–42. doi: 10.1038/s41584-023-…

…diovascular, renal events, and safety outcomes in patients with systemic lupus erythematosus and comorbid type 2 diabetes: a population-based target trial e…

…antibody that inhibits blymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63(12):3918–30. doi: 10.1002/art.30613Na…

…l JT, et al. Deucravacitinib, a tyrosine kinase 2 inhibitor, in systemic lupus erythematosus: a phase II, randomized, double-blind, placebo-controlled trial…

…esulting in symptom improvement while continuing siltuximab for Castleman disease.Results The patient‘s complex clinical course underlines the ch…

…Lupus arthritis sometimes receives less attention than other manifestations of …

…management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768–79…

…tion between antiphospholipid antibodies and vascular events in systemic lupus erythematosusMethods This is a retrospective study including 91 patients with system…

…without any recurrence of the testicular vasculitis.Conclusions Lupus orchitis is a rare manifestation of systemic lupus erythematosus (SLE) t…

…Objectives Systemic lupus erythematosus (SLE) is a polymorphic connective tissue disease characterized …

… years vs. <3 years.Abstract PT6:02 Table 1Associations between systemic lupus erythematosus and heart failure and cardiomyopathyAbstract PT6:02 Figure 1Ris…

…ed to identify autoantibody-defined subgroups at diagnosis in a Systemic Lupus Erythematosus (SLE) inception cohort and assess their associations with clini…